Delivery Order SPE2DB22D2007-SPE2DB24FH9UH
Award Date 2/21/24
Potential Completion Date 2/22/24
Potential Value $8.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The $5,889.65 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies...
- This federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The $1,741.62 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of April 29, 2024. This is a delivery order placed against Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The $8,708.10 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of July 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,748.20 and was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type and runs through December 1, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award is for the delivery of the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, valued at $1,554.57, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price, and the ultimate completion date is December 5, 2023. This award is not associated with a set-aside designation, indicating full and open competition. Amerisourcebergen Drug...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $8,212.23 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) for the product Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The contract has an ultimate completion date of September 16, 2024 and was awarded on September 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award is for the delivery of Ozempic 2mg/dose (8mg/3mL) 3mL, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $77,430.83 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 11, 2024 with a completion date of December 12, 2024. This delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The $3,664.43 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- This federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The award, valued at $20,097.04, was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a firm fixed price and an ultimate completion date of September 14, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials. The $8,889.22 fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical on September 5, 2024, with a completion date of September 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FH9UHDelivery Order
This federal contract award is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The $8,338.01 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on February 21, 2024 with a completion date of February 22, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Generated 5/14/25, 10:30 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 2/21/24 |